Development of pharmacophoric model of condensed pyridine and pyrimidine analogs as hydroxymethyl glutaryl coenzyme A reductase inhibitors.
Indian J Biochem Biophys
;
2006 Feb; 43(1): 32-6
Article
in English
| IMSEAR
| ID: sea-28533
ABSTRACT
Quantitative structure-activity relationship (QSAR) has been established on a series of thirty-eight compounds of four different sets of condensed pyridine and pyrimidine analogs, for their hydroxymethyl glutaryl coenzyme (HMG-CoA) reductase inhibitor activity, in order to understand the essential structural requirement for binding with receptor, in terms of common biophoric and secondary sites employing APEX-3D software. Among several 3D pharmacophoric models with different sizes and arrangements, one model was selected based on r2 = 0.8, chance<0.001, match equivalent to 0.38 and all the 38 compounds were considered. The results suggest that hydrophobicity, hydrogen acceptor and optimum steric refractivity play a dominant role in the inhibition of HMG-CoA reductase. The information obtained from the present study can be used to design and predict more potent molecules as HMG-CoA reductase inhibitors, prior to their synthesis.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Pyridines
/
Pyrimidines
/
Drug Design
/
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Quantitative Structure-Activity Relationship
/
Models, Chemical
Type of study:
Prognostic study
Language:
English
Journal:
Indian J Biochem Biophys
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS